Cargando…

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

Detalles Bibliográficos
Autores principales: Coll, Rebecca C., O'Neill, Luke A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/
http://dx.doi.org/10.1371/annotation/78d328b9-2c8c-4978-84b1-7e6a0b12ada1
_version_ 1782282958416117760
author Coll, Rebecca C.
O'Neill, Luke A. J.
author_facet Coll, Rebecca C.
O'Neill, Luke A. J.
author_sort Coll, Rebecca C.
collection PubMed
description
format Online
Article
Text
id pubmed-3762986
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37629862013-09-13 Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes Coll, Rebecca C. O'Neill, Luke A. J. PLoS One Correction Public Library of Science 2013-07-09 /pmc/articles/PMC3762986/ http://dx.doi.org/10.1371/annotation/78d328b9-2c8c-4978-84b1-7e6a0b12ada1 Text en © 2013 Public Library of Science http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Coll, Rebecca C.
O'Neill, Luke A. J.
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_full Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_fullStr Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_full_unstemmed Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_short Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_sort correction: the cytokine release inhibitory drug crid3 targets asc oligomerisation in the nlrp3 and aim2 inflammasomes
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/
http://dx.doi.org/10.1371/annotation/78d328b9-2c8c-4978-84b1-7e6a0b12ada1
work_keys_str_mv AT collrebeccac correctionthecytokinereleaseinhibitorydrugcrid3targetsascoligomerisationinthenlrp3andaim2inflammasomes
AT oneilllukeaj correctionthecytokinereleaseinhibitorydrugcrid3targetsascoligomerisationinthenlrp3andaim2inflammasomes